Can a High-Fat drink help Alzheimer's? small study tests safety
NCT ID NCT02912936
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a ketogenic drink made from medium chain triglycerides (MCTs) in 43 people with Alzheimer's disease or a type of frontotemporal dementia. The goal was to see if it was safe and tolerable, and to measure ketone levels in the blood. It was a small, early-stage trial focused on safety, not on whether the drink improves symptoms.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
ketogenic medium chain triglyceride (MCT) drink
What this could lead to
If it works, this could point toward a dietary supplement that helps manage symptoms in Alzheimer's or related dementias by providing an alternative brain fuel.
What could go wrong
This is a very early, small pilot study focused on safety and tolerability, not effectiveness. The results may not apply to all patients, and any benefits are uncertain.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER S DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Djavad Mowafaghian Centre for Brain Health
Vancouver, British Columbia, V6T 1Z3, Canada